Alanosine
(Redirected from SDX-102)
Template:Short description Template:Drugbox
Alanosine (also called SDX-102)[1] is a substance that has been studied for the treatment of pancreatic cancer.[2] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.Template:Update inline
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".